Looking for Clues in Art
We think of art, whether modern, post modern, classical, or even neolithic, as a way to express the painter's thoughts on their surroundings. It doesn't matter if the scene is posed, still life, mythical or something else. The artist take that and makes their artwork a memory of their surroundings to last for centuries.Recently researchers looking atbreast cancer iconograpy through history found two portraits from the early 16th century showing late stage breast cancer." Signs of breast cancer can clearly be seen in " The Night " , painted by Michele di Rodolfo del Ghirlandaio, and " The Allegory of Fortitude " , depicted by Maso di San Friano. "If you look at the close ups of these two paintings in theForbes article you can see them clearly. In addition it is noted that the Renaissance was a time of medical advancement so perhaps this was a way of showing the realities of life. What have other artists done? Intentionally omitted body defects so as not to show signs of disease?But I also would not want to be the patients in the photos which show necrotizing tissue.
Cowden syndrome (CS) is a multiple hamartoma syndrome associated with the development of various tumors, including endometrial cancer. However, the histology of CS-associated endometrial cancer remains to be fully described. To our knowledge, this is the first report of a patient with CS having endometrial endometrioid carcinoma with ovarian metastasis demonstrating morula-like features. A 31-yr-old, nulliparous, Japanese woman presented with abnormal genital bleeding. Endometrial biopsy revealed endometrioid carcinoma with an extensive morular formation, partially resembling atypical polypoid adenomyoma (APAM). Moreover, ...
PET/MRI is better than MRI alone for the detection and staging of nodes and...Read more on AuntMinnie.comRelated Reading: Can FDG-PET/MRI replace biopsy in breast cancer cases? PET/MRI sheds light on cerebral vascular risk factors PET/MRI can pinpoint causes of chronic extremity pain SNMMI: FDG-PET/MRI improves pain diagnosis, management PET/MRI offers view to atherosclerotic disease origin
Basel, 13 December 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the Phase III IMspire150 study, in people with previously untreated BRAF V600 mutation-positive advanced melanoma, met its primary endpoint of progression-free survival (PFS). The study showed adding Tecentriq ® (atezolizumab) to Cotellic® (cobimetinib) and Zelboraf® (vemurafenib) helped to reduce the risk of disease worsening or death, compared to placebo plus Cotellic and Zelboraf. A significant and clinically meaningful improvement in PFS was demonstrated in the study. The safety ...
Future Oncology, Ahead of Print.
Future Oncology, Ahead of Print.
A current phase 3 trial showed that partial breast irradiation — as opposed to irradiating the whole breast — could be a viable alternative in patients with early, low-risk breast cancer.Medscape Medical News
Analyst, 2020, Advance Article DOI: 10.1039/C9AN01830A, PaperRenhui Zhan, Xiaofeng Li, Lixin Zang, Kehua Xu A nanoprobe based on high-fidelity Au –Se bonds was developed for the imaging and real-time monitoring of the sequential activation of uPA and MMP-2 and its application to evaluate the invasive potential of breast cancer cells. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry
Trastuzumab emtansine showed no disease-free survival or safety advantage over paclitaxel + trastuzumab in the adjuvant setting for patients with stage 1 HER2-positive breast cancer.Medscape Medical News